- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
SUPPORT PHILSTAR
About Us |
Contact Us |
Advertise |
Privacy Policy |
Member Agreement |
Copyright Notice
Copyright © 2024. Philstar Global Corp. All Rights Reserved
X
+ Follow ONTARGET Tag
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 134000 [Title] => Study centers in 40 countries involved in heart pr [Summary] => A total of 793 study centers in 40 countries have been recruited to enroll 28,400 patients over two years for the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET) cardiovascular protection trial.
Boehringer Ingelheim, one of the worlds leading pharmaceutical companies, announced this at the European Society of Cardiology Congress in Stockholm, Sweden.
[DatePublished] => 2001-09-17 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 83550 [Title] => Boehringer Ingelheim sets largest cardiovascular protection trial [Summary] => MILAN, Italy Boehringer Ingelheim has announced plans for the largest cardiovascular protection trial ever conducted on patients intolerant to angiotensin converting enzyme (ACE) inhibitors.
The study, announced at the European Society of Hypertension meeting, will examine the effects of the angiotensin III recepto antagonist (ARB) Micardis or telmisartan, on these patients. About 5,000 patients worldwide will be enrolled in the study.
[DatePublished] => 2001-06-18 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
ONTARGET
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 134000 [Title] => Study centers in 40 countries involved in heart pr [Summary] => A total of 793 study centers in 40 countries have been recruited to enroll 28,400 patients over two years for the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET) cardiovascular protection trial.
Boehringer Ingelheim, one of the worlds leading pharmaceutical companies, announced this at the European Society of Cardiology Congress in Stockholm, Sweden.
[DatePublished] => 2001-09-17 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 83550 [Title] => Boehringer Ingelheim sets largest cardiovascular protection trial [Summary] => MILAN, Italy Boehringer Ingelheim has announced plans for the largest cardiovascular protection trial ever conducted on patients intolerant to angiotensin converting enzyme (ACE) inhibitors.
The study, announced at the European Society of Hypertension meeting, will examine the effects of the angiotensin III recepto antagonist (ARB) Micardis or telmisartan, on these patients. About 5,000 patients worldwide will be enrolled in the study.
[DatePublished] => 2001-06-18 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
September 17, 2001 - 12:00am
June 18, 2001 - 12:00am
Recommended
President Ferdinand Marcos Jr. on Monday signed a new law that streamlines tax incentives for businesses in the Philippines, including the taxation of companies in special economic zones.
1 day ago
During the conference, Finance Secretary Ralph Recto emphasized the importance of a business environment that supports consistent progress.
3 days ago
Speaker Martin Romualdez and eight other lawmakers filed House Bill 11034, seeking to move the BARMM parliamentary elections from May 12, 2025 to May 11, 2026.
6 days ago
Lotto Nov 12, 2024
EZ2/LVM - 14 21
SUERTRES - 0 3 2
6D Lotto - 5 3 6 8 3 7
6/42 Lotto - 27 17 29 9 8 32
P9,508,486.00
6/49 Super Lotto - 10 23 3 14 44 8
P122,257,137.00
6/58 Ultra Lotto - 10 22 11 5 38 40
P115,983,208.00
Forex
February 12, 2018
- 12:00 am
- 12:00 am
1$ : P51.66